Cargando…

The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet’s Retinal Vasculitis

Background: No study has evaluated the effectiveness of Adalimumab (ADA) as first-line in treatment-naïve patients with retinal vasculitis due to Behçet’s Uveitis (BU). Objective: To compare the efficacy of ADA plus conventional therapy and conventional therapy alone as initial treatments in naïve B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shizhao, Huang, Zhaohao, Hu, Yunwei, Zhang, Jian, Liu, Xiuxing, Li, He, Xie, Lihui, Wen, Feng, Liang, Dan, Su, Wenru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258106/ https://www.ncbi.nlm.nih.gov/pubmed/34239438 http://dx.doi.org/10.3389/fphar.2021.609148

Ejemplares similares

Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis
por: Hu, Yunwei, et al.
Publicado: (2020)

Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy
por: Yang, Shizhao, et al.
Publicado: (2022)

Systemic glucocorticoid-free therapy with adalimumab plus immunosuppressants versus conventional therapy in treatment-naïve Vogt-Koyanagi-Harada disease patients
por: Yang, Shizhao, et al.
Publicado: (2022)

IL-38: A New Player in Inflammatory Autoimmune Disorders
por: Xie, Lihui, et al.
Publicado: (2019)

Adalimumab in the management of Behçet’s disease
por: Ueda, Atsuhisa, et al.
Publicado: (2015)

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease
por: Kaji, Mariko, et al.
Publicado: (2015)

The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID‐19
por: Tang, Hao, et al.
Publicado: (2020)

Insights gained from single-cell analysis of immune cells in tofacitinib treatment of Vogt-Koyanagi-Harada disease
por: Liu, Xiuxing, et al.
Publicado: (2022)

Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis
por: Chen, Binyao, et al.
Publicado: (2022)

Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis
por: Huang, Zhaohao, et al.
Publicado: (2021)

Pharmacological Inhibition of Caspase-8 Suppresses Inflammation-Induced Angiogenesis in the Cornea
por: Tian, Yunzhe, et al.
Publicado: (2020)

Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn’s disease
por: Chen, Liang, et al.
Publicado: (2022)

Pulmonary Sarcoidosis in Behçet’s Disease Treated with Adalimumab
por: Louro, Marlene, et al.
Publicado: (2017)

Effects of poor sleep on the immune cell landscape as assessed by single-cell analysis
por: Liu, Xiuxing, et al.
Publicado: (2021)

Reperfusion of retinal ischemia in retinal occlusive vasculitis with nicotinic acid and infliximab in Adamantiades-Behçet's disease
por: Al-Moujahed, Ahmad, et al.
Publicado: (2021)

Correlation between Fluorescein Angiographic Findings and Visual Acuity in Behçet Retinal Vasculitis
por: Kim, Min, et al.
Publicado: (2015)

Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy
por: Huang, Mao-Xin, et al.
Publicado: (2021)

Therapeutic Effect of IL-38 on Experimental Autoimmune Uveitis: Reprogrammed Immune Cell Landscape and Reduced Th17 Cell Pathogenicity
por: Li, He, et al.
Publicado: (2021)

Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study
por: Wang, Fang, et al.
Publicado: (2023)

Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases
por: Tanida, Satoshi, et al.
Publicado: (2016)

Assessment and Comparison of the Efficacy of Methotrexate, Prednisolone, Adalimumab, and Tocilizumab on Multipotency of Mesenchymal Stem Cells
por: Liu, Shuang, et al.
Publicado: (2020)

Peripapillary optical coherence tomography as an alternative to fluorescein angiography for monitoring Behcet’s retinal vasculitis
por: Zarei, Mohammad, et al.
Publicado: (2021)

Anticoagulation in Behçet related intrathoracic vasculitis
por: Nokes, Brandon, et al.
Publicado: (2018)

Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points
por: Su, Jinmei, et al.
Publicado: (2020)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Biao, et al.
Publicado: (2021)

Retinal vasculitis and skin ulcer preceding Budd–Chiari syndrome in a patient with Behcet's disease
por: Bhatia, Priyavrat, et al.
Publicado: (2020)

Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
por: Xu, Lankai Cathy, et al.
Publicado: (2023)

Adalimumab in Treatment of Uveitis in Pediatric Behcet’s Disease–a Case Report
por: Halilbasic, Meliha, et al.
Publicado: (2021)

Comment to “Deep vein thrombosis induced by vasculitis in the Behçet's syndrome”
por: Guo, Ya-Nan, et al.
Publicado: (2019)

Delanzomib, a Novel Proteasome Inhibitor, Combined With Adalimumab Drastically Ameliorates Collagen-Induced Arthritis in Rats by Improving and Prolonging the Anti-TNF-α Effect of Adalimumab
por: Wang, Lei, et al.
Publicado: (2021)

Secondary Syphilis with Nodular Vasculitis Mimicking Behçet's Disease
por: Jo, Jaemin, et al.
Publicado: (2013)

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021)

Behçet's disease-induced massive small intestinal bleeding successfully treated with adalimumab
por: Liu, PH, et al.
Publicado: (2023)

Case Report: Severe thrombocytopenia induced by adalimumab in rheumatoid arthritis: A case report and literature review
por: Liao, Tiantian, et al.
Publicado: (2022)

Therapeutic Effects of Upadacitinib on Experimental Autoimmune Uveitis: Insights From Single-Cell Analysis
por: Huang, Zhaohao, et al.
Publicado: (2023)

Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
por: D'Angelo, Salvatore, et al.
Publicado: (2019)

Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2/Pim1 axis
por: Liu, Xiuxing, et al.
Publicado: (2023)

Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behçet’s Uveitis: A Randomized Controlled Prospective Study
por: Qian, Yujing, et al.
Publicado: (2021)

Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis
por: Li, He, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_83i2iji6cb09032f2fqegdi7nu